According to a new report, published by KBV research, The Global Orthopedic Imaging Equipment Market size is expected to reach $7.5 billion by 2031, rising at a market growth of 5.7% CAGR during the forecast period.
The Diagnostic Imaging Centers segment is anticipating a CAGR of 6.1% during (2024 - 2031). This crucial segment provides specialized imaging services focused on the diagnosis and assessment of musculoskeletal conditions. These centers offer a range of imaging modalities specifically tailored to orthopedic patients' needs, including X-ray, magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, and others.
The X-ray segment is leading the Global Orthopedic Imaging Equipment Market by Modality in 2023; thereby, achieving a market value of $2.3 billion by 2031. The X-ray segment within the market pertains to using X-ray technology specifically for imaging and diagnosing musculoskeletal conditions. X-ray imaging, or radiography, is a widely used modality in orthopedics for visualizing bones and detecting abnormalities such as fractures, dislocations, and degenerative changes.
The Arthritis segment is registering a CAGR of 7.3% during (2024 - 2031). Servicing individuals afflicted with rheumatoid arthritis, osteoarthritis, and other inflammatory arthropathies, the arthritis segment constitutes a substantial portion of the orthopedic imaging equipment market. Its applications include the diagnosis and management of such conditions. Arthritis is a condition that results in progressive joint damage, inflammation, pain, stiffness, and a decline in quality of life; these symptoms collectively contribute to diminished mobility.
Full Report: https://www.kbvresearch.com/orthopedic-imaging-equipment-market/
The North America region dominated the Global Orthopedic Imaging Equipment Market by Region in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $2.5 billion by 2031. The Europe region is experiencing a CAGR of 5.3% during (2024 - 2031). Additionally, The Asia Pacific region would exhibit a CAGR of 6.4% during (2024 - 2031).
By End-use
By Modality
By Indication
By Geography